Best Quality Carbapenem Antibiotics Imipenem and Cilastatin Sodium for Injection

• Application: Internal Medicine
• Usage Mode: Internal Use
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Powder
• Type: Organic Chemicals
• Model NO.: 0.5g; 1.0g
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: 10vials/Box; 50vials/Box
• Trademark: Reyoung
• Origin: China

Product Description

 

Imipenem and Cilastatin Sodium for Injection is a very broad-spectrum antibiotic, especially suitable for mixed infections caused by multiple pathogens and aerobic/anaerobic bacteria, as well as early treatment before the pathogen is identified. This product is suitable for the following infections caused by sensitive bacteria, intra-abdominal infection, lower respiratory tract infection, gynecological infection, sepsis, urogenital tract infection, bone and joint infection, skin and soft tissue infection, endocarditis 2. This product is suitable for treatment Mixed infection caused by sensitive aerobic/anaerobic strains. 3. It has been demonstrated that this product has potent antibacterial activity against infections caused by many cephalosporin-resistant bacteria, including aerobic and anaerobic Gram-positive and Gram-negative bacteria; these bacteria are resistant to Cephalosporin antibiotics include cefazolin, cefoperazone, cefotaxime, cefoxitin, cefotaxime, carboxamides cefamandol, ceftazidime, and ceftriaxone. Likewise, many are resistant to aminoglycoside antibiotics (eg, gentamicin amikacin, tobramycin) and/or penicillins (ampicillin, carbenicillin, penicillin, ticarcillin, piperacillin, a Loxicillin, mezlocillin) infection caused by bacteria, the use of this product is still effective. 4. This product is not suitable for the treatment of meningitis.

Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is certificated by GMP, ISO9001, ISO14001, OHS18001. The trademark "REYOUNG" is famous trademark of China.

 As a professional pharmaceutical manufacturer, Reyoung Pharma is the first enterprise to manufacture powder for injection in Shandong province. The sales and marketing network for its products covers more than 70 countries all over the world.

Reyoung Pharma commenced international business and exported products in 1997. Reyoung Pharma, with an excellent sales & documentation team, owned over 20 years experience in the international transaction and registered products in different countries. Reyoung Pharma has passed the GMP inspection of Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d′Ivoire, Pakistan, Ukraine, Philippines, Cambodia, etc. Products have been exported to Asia, South America, Africa, CIS Countries, Middle East and Europe including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, Denmark, and so on.

This product is used for treatment of moderate to severe infections caused by β-lactamase-producing bacteria that are resistant to cefoperazone monotherapy and sensitive to this product. When used for the treatment of mixed infections caused by cefoperazone single-drug-sensitive bacteria and cefoperazone single-drug-resistant β-lactamase-producing bacteria sensitive to this product, no additional antibiotics are required. Lower respiratory tract infection: susceptible to β-lactamase-producing Pseudomonas aeruginosa, Streptococcus pneumoniae and other Streptococcus, Klebsiella pneumoniae and other Klebsiella species, Haemophilus influenzae, Staphylococcus aureus, etc. bacterial pneumonia, acute exacerbations of chronic bronchitis, acute bronchitis, lung abscesses and other lung infections. Urogenital infection: acute pyelonephritis, acute pyelonephritis caused by sensitive bacteria such as β-lactamase-producing Escherichia coli, Proteus, Klebsiella, Pseudomonas aeruginosa, and Staphylococcus Exacerbations, complicated urinary tract infections, endometritis, gonorrhea, and other reproductive tract infections. Abdominal and pelvic infections.